Stonehouse Jon P's Form 4 filing
Biocryst Pharmaceuticals Inc (BCRX) · filed Dec 19, 2022
- Accession no.
- 0001127602-22-027894
- Filed
- Dec 19, 2022
- Trade date
- Dec 15, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $153.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stonehouse Jon PCIK 0001385496 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2022 | Common Stock | SSaleDisposed | −14,100 | $10.90 | −$153,690 | 887,730 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.